ICE Bioscience

Beijing, China Founded: 2010 • Age: 16 yrs
Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening
Request Access

About ICE Bioscience

ICE Bioscience is a company based in Beijing (China) founded in 2010.. ICE Bioscience has raised $14.03 million across 2 funding rounds from investors including E-Town International Investment & Development, Alwin Capital and Yida Capital. ICE Bioscience operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and BCI Pharma, among others.

  • Headquarter Beijing, China
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14.03 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ICE Bioscience

ICE Bioscience has successfully raised a total of $14.03M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (26 Sep 2022)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Series C - ICE Bioscience Valuation E-Town International Investment & Development
Sep, 2022 Amount Series B - ICE Bioscience Valuation Jifeng Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ICE Bioscience

ICE Bioscience has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include E-Town International Investment & Development, Alwin Capital and Yida Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments are managed on a global scale.
Founded Year Domain Location
Alwin Capital is focused on life sciences investment opportunities.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ICE Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ICE Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ice Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ICE Bioscience

ICE Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and BCI Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
domain founded_year HQ Location
High-dimensional immune profiling services are delivered via proprietary platform.
domain founded_year HQ Location
A CRO that provides phenotypic assay development and screening services.
domain founded_year HQ Location
Custom human cell engineering and drug discovery services are provided.
domain founded_year HQ Location
Contract research services in cancer and neuroinflammation are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ice Bioscience

Frequently Asked Questions about ICE Bioscience

When was ICE Bioscience founded?

ICE Bioscience was founded in 2010 and raised its 1st funding round 12 years after it was founded.

Where is ICE Bioscience located?

ICE Bioscience is headquartered in Beijing, China.

Is ICE Bioscience a funded company?

ICE Bioscience is a funded company, having raised a total of $14.03M across 2 funding rounds to date. The company's 1st funding round was a Series B of $14.03M, raised on Sep 26, 2022.

What does ICE Bioscience do?

ICE Bioscience was founded in 2010 and is based in Beijing, China. As a preclinical contract research organization, expertise in electrophysiology is utilized to deliver ion channel-based screening services. Cardiac safety assessments, such as hERG testing and QT-prolongation evaluation, are conducted. Profiling of voltage-gated, ligand-gated, CRAC, and chloride channels is offered. In-vitro high-throughput screening, including GPCR and protein kinase assays along with cell line development, is also provided.

Who are the top competitors of ICE Bioscience?

ICE Bioscience's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.

Who are ICE Bioscience's investors?

ICE Bioscience has 9 investors. Key investors include E-Town International Investment & Development, Alwin Capital, Yida Capital, Jifeng Ventures, and CICC Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available